Literature DB >> 32376805

Signaling pathways predisposing to chronic kidney disease progression.

Mohamad Zaidan1,2, Martine Burtin1, Jitao David Zhang3, Thomas Blanc1,4, Pauline Barre1, Serge Garbay1, Clément Nguyen1, Florence Vasseur1, Lucie Yammine1, Serena Germano1, Laura Badi3, Marie-Claire Gubler5, Morgan Gallazzini1, Gérard Friedlander1,6, Marco Pontoglio1, Fabiola Terzi1.   

Abstract

The loss of functional nephrons after kidney injury triggers the compensatory growth of the remaining ones to allow functional adaptation. However, in some cases, these compensatory events activate signaling pathways that lead to pathological alterations and chronic kidney disease. Little is known about the identity of these pathways and how they lead to the development of renal lesions. Here, we combined mouse strains that differently react to nephron reduction with molecular and temporal genome-wide transcriptome studies to elucidate the molecular mechanisms involved in these events. We demonstrated that nephron reduction led to 2 waves of cell proliferation: the first one occurred during the compensatory growth regardless of the genetic background, whereas the second one occurred, after a quiescent phase, exclusively in the sensitive strain and accompanied the development of renal lesions. Similarly, clustering by coinertia analysis revealed the existence of 2 waves of gene expression. Interestingly, we identified type I interferon (IFN) response as an early (first-wave) and specific signature of the sensitive (FVB/N) mice. Activation of type I IFN response was associated with G1/S cell cycle arrest, which correlated with p21 nuclear translocation. Remarkably, the transient induction of type I IFN response by poly(I:C) injections during the compensatory growth resulted in renal lesions in otherwise-resistant C57BL6 mice. Collectively, these results suggest that the early molecular and cellular events occurring after nephron reduction determine the risk of developing late renal lesions and point to type I IFN response as a crucial event of the deterioration process.

Entities:  

Keywords:  Chronic kidney disease; Mouse models; Nephrology

Mesh:

Substances:

Year:  2020        PMID: 32376805      PMCID: PMC7253021          DOI: 10.1172/jci.insight.126183

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  44 in total

1.  Progressive glomerulonephritis in mice treated with interferon preparations at birth.

Authors:  I Gresser; C Maury; M Tovey; L Morel-Maroger; F Pontillon
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

Review 2.  Pathogen recognition by the innate immune system.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Int Rev Immunol       Date:  2011-02       Impact factor: 5.311

3.  KIM-1-mediated phagocytosis reduces acute injury to the kidney.

Authors:  Li Yang; Craig R Brooks; Sheng Xiao; Venkata Sabbisetti; Melissa Y Yeung; Li-Li Hsiao; Takaharu Ichimura; Vijay Kuchroo; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

Review 4.  Type I interferons (alpha/beta) in immunity and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Roberto Baccala; Bruce Beutler; Dwight H Kono
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 5.  Interferon-alpha and -beta in kidney inflammation.

Authors:  Hans-Joachim Anders; Julia Lichtnekert; Ramanjaneyulu Allam
Journal:  Kidney Int       Date:  2010-03-17       Impact factor: 10.612

6.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

Authors:  E Pillebout; M Burtin; H T Yuan; P Briand; A S Woolf; G Friedlander; F Terzi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity.

Authors:  Anetta Härtlova; Saskia F Erttmann; Faizal Am Raffi; Anja M Schmalz; Ulrike Resch; Sharath Anugula; Stefan Lienenklaus; Lisa M Nilsson; Andrea Kröger; Jonas A Nilsson; Torben Ek; Siegfried Weiss; Nelson O Gekara
Journal:  Immunity       Date:  2015-02-17       Impact factor: 31.745

8.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.

Authors:  Hyun Mi Kang; Seon Ho Ahn; Peter Choi; Yi-An Ko; Seung Hyeok Han; Frank Chinga; Ae Seo Deok Park; Jianling Tao; Kumar Sharma; James Pullman; Erwin P Bottinger; Ira J Goldberg; Katalin Susztak
Journal:  Nat Med       Date:  2014-12-01       Impact factor: 53.440

Review 9.  Immune sensing of DNA.

Authors:  Søren R Paludan; Andrew G Bowie
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  3 in total

1.  A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data.

Authors:  Yueshan Zhao; Yue Wang; Da Yang; Kangho Suh; Min Zhang
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Diet Significantly Influences the Immunopathology and Severity of Kidney Injury in Male C57Bl/6J Mice in a Model Dependent Manner.

Authors:  John E Brus; Daniel L Quan; Kristin J Wiley; Brittney Browning; Hannah Ter Haar; Riley Lutz; Jeffrey F Houghton; Joseph C Gigliotti
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

3.  Proteomics-Based Identification of Interaction Partners of the Xenobiotic Detoxification Enzyme FMO3 Reveals Involvement in Urea Cycle.

Authors:  Zhao Yang; Paul M Stemmer; Michael C Petriello
Journal:  Toxics       Date:  2022-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.